The USA-India Chamber of Commerce (USAIC), a bilateral body committed to promoting and facilitating trade and investment between the two countries, is organizing its annual Indo-US BioPharma and Healthcare Summit in Boston on May 14.
The Summit is part of an ongoing dialogue with all the stakeholders, industry, investors, policy makers and academia, said USAIC President Karun Rishi, in a statement.
“We have created an ecosystem where all stake holders meet to share and learn. This unique platform creates mutually beneficial opportunities for the US and Indian industry necessary to take the business to the next level,” he said.
“The platform (Summit) encourages both established and emerging companies. Over the last few years, our initiatives, regular follow-up and consistency of approach has greatly contributed to industry-friendly policies, fostered innovation and created business opportunities,” Rishi added.